ALung raises $2.6m
Artificial lung-like device developer ALung Technologies raised $2.6 million in a new round of debt and options financing, according to an SEC filing posted this week. The Pittsburgh, Penn.-based company is developing the Hemolung device, an extracorporeal carbon dioxide removal system that works by removing carbon dioxide and delivering oxygen directly to a patient’s blood via a small catheter inserted into the jugular or femoral vein. ALung Technologies has not yet stated how it plans to spend money raised in the round. Money in the round came from 37 unnamed sources, with the company seeking another $1.4 million before closing the round. The 1st sale in the round was reported on Dec. 27, according to the SEC filing. Last month, ALung Technologies said it raised $2.6 million in a new round of financing, according to an SEC filing posted this week. Last January, ALung Technologies reported raising $10.8 million in a round of debt financing. A month earlier, the company said its Hemolung RAS extracorporeal carbon dioxide removal device was selected for use in the world’s 1st pivotal trial of ECCO2R technology used to treat patients with acute respiratory failure. The post ALung raises $2.6m appeared first on MassDevice.
Publication date: Available online 16 February 2019Source: Social Science &MedicineAuthor(s): Athena EngmanAbstractThe concept of biographical disruption has now enjoyed nearly 40 years of use in medical sociology. This paper argues that taking an embodied approach to biographical disruption helps to explain the concept's enduring efficacy. Drawing on the work of Maurice Merleau-Ponty and contemporary theories of embodiment inspired by his phenomenology, this paper advances that biographical disruption involves, in the first instance, a disruption to the ability to enact an embodied orientation towards the world. Biogr...
Publication date: Available online 15 February 2019Source: Journal of Cardiology CasesAuthor(s): Takahiro Okano, Ayako Okada, Hiroaki Tabata, Hideki Kobayashi, Wataru Shoin, Koji Yoshie, Yasutaka Oguchi, Morio Shoda, Koichiro KuwaharaAbstractA 73-year-old woman underwent radiofrequency hot balloon ablation (RHBA) for paroxysmal atrial fibrillation. After delivery into the left inferior pulmonary vein (LIPV), the guidewire perforated the venous wall. We injected contrast medium while the inflated balloon occluded the PV. Subsequently, bronchial-pulmonary venous fistula (BPVF) occurred and the severe hypoxia caused pulseless...
In this report, early graft dysfunction was diagnosed at day 3 and the patient was empirically treated with antibiotics and high dose corticosteroid therapy. Death occurred on the 29th post-operative day and an autopsy revealed abundance of foamy macrophages in lung tissue consistent with ASMD cells.
Professor Francis Fontan, the pioneer in the field of congenital heart surgery and former president of the European Association for Cardio-Thoracic Surgery, recently passed away in January 2018. The ‘Fontan operation’,1 the final stage in a series of cardiac repairs for children with single ventricle anatomy, saved the lives of numerous children and is undoubtedly one of the greatest milestones in surgical history. However, Professor Fontan himself was among the first to notice the palliati ve nature of the Fontan circulation.
Iavicoli Silicosis is a progressive fibrotic lung disease that is caused by the inhalation of respirable crystalline silica. Due to its high silica content, artificial stone (AS) can become a possible source of hazardous dust exposure for workers that are employed in the manufacturing, finishing, and installing of AS countertops. Therefore, the aim of this review was to verify the association between AS derived silica exposure and silicosis development, and also then define the pathological characteristics of the disease in relation to specific work practices and preventive and protective measures that were adopted in...
Tiffany Senter (pictured) of Shasta Lake City, California is only 25, but she's been at deaths door twice. Tiffany was born with cystic fibrosis and has had to have two lung transplants.
By analyzing tumor characteristics such as structure, shape, and size, an artificial...Read more on AuntMinnie.comRelated Reading: AI may predict lymph node metastasis in gastric cancer AI can predict breast cancer molecular subtypes on MRI Russian AI detects lung cancer on CT in 20 seconds AI can differentiate glioblastoma, brain metastasis AI uses features outside nodules to predict malignancy
Condition: Incidental Lung Nodule Intervention: Sponsor: University Hospital, Strasbourg, France Not yet recruiting